714leukemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which 714leukemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 1

NCT00671112

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

RATIONALE: Everolimus and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is…

United States30 participantsStarted 2008-06

Treatment: Bortezomib, Everolimus